![]() |
市場調查報告書
商品編碼
1830968
CT掃描儀市場CT Scanner Market |
CT 掃描儀市場預計將從 2024 年的 70.1 億美元擴大到 2031 年的 101 億美元,2025 年至 2031 年的複合年成長率預計為 5.35%。
分析師的觀點
CT掃描儀市場分析發現,關鍵的成長因素包括慢性病發病率上升、早期診斷需求日益成長以及醫療基礎設施的進步。此外,CT掃描儀技術的創新預計將在2022年至2030年期間創造新的市場趨勢。
電腦斷層掃描 (CT) 掃描儀是一種醫學影像設備,它利用不同角度的 X 光產生人體骨骼、血管和軟組織的詳細影像,比標準 X 光提供更詳細的資訊。 CT 掃描儀通常用於評估因車禍或其他創傷而遭受內傷的患者。這種影像技術幾乎可以顯示所有身體部位,有助於診斷損傷或疾病。此外,在疾病診斷過程中,它也用於規劃患處的醫療、手術或放射治療。
市場概況慢性病發病率上升推動 CT 掃描儀市場發展根據美國國家生物醫學影像和生物工程研究所 2022 年 6 月發布的報告,CT 已成為識別腹部潛在癌症或病變的可靠篩檢工具。當懷疑有各種心臟疾病或異常時,可能會建議進行心臟 CT 掃描。頭部 CT 掃描還可以幫助檢測可能導致中風、出血和其他疾病的損傷、腫瘤和血栓。它們可以評估肺部是否有癌症、肺栓塞(血栓)、過多的液體以及其他疾病,例如肺氣腫或肺炎。 CT 掃描由於其比傳統 X 光更清晰的細節,特別適用於識別複雜的骨折、嚴重受損的關節或骨癌。因此,心血管疾病、癌症、神經系統疾病和骨科問題等慢性疾病的日益流行,導致全球大量患者接受電腦斷層掃描。美國國家衛生統計中心報告稱,2021年美國新增癌症病例1,898,160例,凸顯了對電腦斷層掃描儀日益成長的需求。此外,哈佛健康雜誌2021年9月的報告顯示,美國每年約進行9,000萬次CT掃描。
領先的公司正在推出先進的技術產品,以提升競爭優勢。例如,2021年4月,日立公司推出了全新設計的Scenaria 64層CT掃描儀,旨在減少輻射暴露,提高效率,並為介入醫生的診療工作提供支援。此次產品的發布是日立在競爭激烈的市場中強化產品供應的策略的一部分。
策略洞察新興趨勢CT掃描儀技術創新引領未來趨勢隨著人們對輻射暴露的擔憂日益加深,CT掃描儀的劑量降低技術也備受關注。這包括迭代重建技術、自動曝光控制和其他劑量最佳化方法的改進,旨在降低輻射劑量的同時保持影像品質。美國癌症協會建議50歲及以上吸菸或有吸菸史的成年人每年進行一次低劑量CT (LDCT) 掃描篩檢,以發現肺癌。
Science Direct 於 2022 年發表的一項研究考察了國家肺部篩檢試驗 (NLST) 中與呼吸系統疾病相關的偶然發現與呼吸系統疾病死亡率 (RDM) 之間的關係,其中不包括 LDCT 篩檢中發現的肺癌。該研究納入了 NLST LDCT 組的 26,722 名參與者,其中 25,002 名參與者接受了基線和後續 LDCT 篩檢。研究發現,肺氣腫和網狀陰影等偶然發現與較高的 RDM 有關。
主要參與者實施的各種策略正在推動市場成長。例如,2023年12月,富士印度公司與Soorya Diagnostics LLP合作,將其最新的CT掃描設備引入Soorya Diagnostics中心,以推廣篩檢文化,並增強該地區獲得優質醫療服務的機會。
報告細分和範圍「CT掃描器市場」根據類型、架構、技術、應用、最終用戶和地理進行分類。根據類型,市場分為固定式和攜帶式CT掃描器。根據架構,CT掃描器市場分為C型臂CT掃描器和O型臂CT掃描器。根據技術,市場細分為高切片CT、中型CT、低切片CT和錐形束CT。基於應用的細分包括腫瘤科、神經科、骨科和其他應用。對於最終用戶,市場分為醫院、診斷中心、研究實驗室和獸醫診所。從地理上看,CT 掃描儀市場分為北美(美國、加拿大和墨西哥)、歐洲(德國、法國、義大利、英國、俄羅斯和歐洲其他地區)、亞太地區(澳洲、中國、日本、印度、韓國和亞太其他地區)、中東和非洲(南非、沙烏地阿拉伯、阿拉伯聯合大公國和中東和非洲其他地區)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地區)。
基於類型的洞察CT掃描儀市場分為固定式和攜帶式CT掃描儀。固定式CT掃描儀在2022年佔據了較大的市場佔有率,預計在2022年至2030年期間將呈現最高的複合年成長率。
基於架構的洞察 CT 掃描儀市場按架構分為 C 臂 CT 掃描儀和 O 臂 CT 掃描儀,其中 C 臂 CT 掃描儀領域在 2022 年引領市場。
基於技術的洞察 CT 掃描儀市場按技術細分為高切片 CT、中型 CT、低切片 CT 和錐形束 CT,其中高切片 CT 細分市場在 2022 年佔據最大市場佔有率。
基於應用的洞察 CT 掃描儀市場按應用細分為腫瘤學、神經病學、骨科和其他應用,其中神經病學應用領域在 2022 年佔據最大的市場佔有率。
基於終端用戶的洞察:CT掃描儀市場按終端用戶分為醫院、診斷中心、研究實驗室和獸醫診所。醫院市場在2022年佔據最大市場佔有率,預計在2022年至2030年期間將實現最高的複合年成長率。
CT掃描儀市場報告範圍區域分析
預計北美將在2022年至2030年期間實現全球CT掃描儀市場的最高複合年成長率。北美在2022年佔據了最大的市場佔有率,預計在整個預測期內都將保持領先地位。北美市場分為美國、加拿大和墨西哥,其中美國佔據最大佔有率,這得益於該地區炎症性疾病的發病率上升、主要行業參與者的存在、醫療保健領域的進步、創新CT掃描系統的引入以及CT掃描技術的進步。
全球 CT 掃描儀市場的主要參與者包括 GE 醫療集團、西門子醫療私人有限公司、荷蘭皇家飛利浦公司、東芝 IT 和控制系統公司、HTSI 醫療解決方案、島津製作所、SAMSUNGHEALTHCARE.COM、東軟集團、美敦力和深圳安科高科技股份有限公司。這些領先公司專注於擴大和多樣化其市場影響力和客戶群,預計這將對 CT 掃描儀市場產生積極影響。
主要市場參與者的一些顯著進展包括:
2022 年 11 月,富士軟片在美國推出了高階 CT 掃描儀 SCENARIA View Focus Edition,該掃描儀採用先進的心臟運動校正技術 Cardio StillShot,可提供比傳統影像重建方法高 6 倍的時間解析度。該設備適用於常規和高級臨床應用,並在 2022 年 RSNA 上推出。 2022 年 4 月,Wipro GE 醫療推出了其先進的 Revolution Aspire CT 掃描儀,該掃描儀完全在印度的 Wipro GE 醫療設備製造工廠設計和製造,提供增強的成像智慧,以實現更準確的臨床診斷。 2021 年 11 月,西門子醫療推出了 Naeotom Alpha,這是第一款在美國和歐洲獲準用於臨床的光子計數 CT 掃描儀,與傳統 CT 探測器相比,它提供了顯著的改進,包括增強的解析度和在超高解析度掃描中將輻射劑量降低高達 45%。
The CT Scanner market is projected to expand from US$ 7.01 billion in 2024 to US$ 10.10 billion by 2031, with an estimated CAGR of 5.35% from 2025 to 2031.
Analyst's Perspective
The analysis of the CT Scanner market identifies key growth factors, including the rising incidence of chronic diseases, an increasing need for early diagnosis, and advancements in healthcare infrastructure. Additionally, innovations in CT scanner technology are expected to create new market trends from 2022 to 2030.
A computerized tomography (CT) scanner is a medical imaging device that utilizes X-rays from various angles to produce detailed images of the body's bones, blood vessels, and soft tissues, offering more detail than standard X-rays. CT scanners are commonly employed to assess individuals who may have sustained internal injuries from car accidents or other traumas. This imaging technique can visualize nearly all body parts, aiding in the diagnosis of injuries or diseases. Furthermore, it is utilized in planning medical, surgical, or radiation treatments for affected areas during disease diagnosis.
Market Overview
Rising Incidence of Chronic Diseases to Drive CT Scanner Market
According to a report by the National Institute of Biomedical Imaging and Bioengineering published in June 2022, CT has become a reliable screening tool for identifying potential cancers or lesions in the abdomen. A heart CT scan may be advised when various cardiac conditions or abnormalities are suspected. CT scans of the head can also help detect injuries, tumors, clots that may lead to strokes, bleeding, and other conditions. They can assess the lungs for cancers, pulmonary embolisms (blood clots), excess fluid, and other diseases such as emphysema or pneumonia. CT scans are particularly useful for identifying complex bone fractures, severely damaged joints, or bone cancers due to their superior detail compared to traditional X-rays. Consequently, the increasing prevalence of chronic conditions like cardiovascular diseases, cancer, neurological disorders, and orthopedic issues has led to a significant patient population undergoing computed tomography scans globally. The National Center for Health Statistics reported 1,898,160 new cancer cases in the US in 2021, highlighting the growing demand for computed tomography scanners. Additionally, a report from Harvard Health in September 2021 indicated that approximately 90.0 million CT scan procedures are conducted annually in the US.
Leading companies are launching advanced technological products to gain a competitive advantage. For example, in April 2021, Hitachi, Ltd. introduced the newly designed Scenaria 64-slice CT scanner, aimed at reducing radiation exposure, enhancing efficiency, and supporting interventionists in their practices. This product launch is part of Hitachi's strategy to strengthen its product offerings in a competitive market.
Strategic Insights
Emerging Trends
Technological Innovations in CT Scanners as a Future Trend
With growing concerns regarding radiation exposure, there has been a significant emphasis on dose-reduction technologies in CT scanners. This includes advancements in iterative reconstruction techniques, automatic exposure control, and other dose optimization methods to lower radiation doses while preserving image quality. The American Cancer Society recommends annual screening with a low-dose CT (LDCT) scan for adults aged 50 and older who smoke or have a history of smoking to detect lung cancer.
A study published by Science Direct in 2022 examined the relationship between incidental findings related to respiratory diseases from the National Lung Screening Trial (NLST) and respiratory disease mortality (RDM), excluding lung cancer detected during LDCT screenings. The study involved 26,722 participants in the NLST LDCT arm, with 25,002 undergoing both baseline and follow-up LDCT screenings. It found that incidental findings such as emphysema and reticular opacities were associated with higher RDM.
Various strategies implemented by key players are propelling market growth. For instance, in December 2023, Fujifilm India partnered with Soorya Diagnostics LLP to place its latest CT scan equipment at Soorya Diagnostics Center, promoting a culture of screening and enhancing access to quality healthcare services in the region.
Report Segmentation and Scope
The "CT scanner market" is categorized based on type, architecture, technology, application, end user, and geography. The market is divided into stationary and portable CT scanners based on type. In terms of architecture, the CT scanner market is split into C-arm CT Scanners and O-arm CT Scanners. By technology, the market is segmented into high slice CT, midsize CT, low slice CT, and cone beam CT. The application-based segmentation includes oncology, neurology, orthopedics, and other applications. For end users, the market is classified into hospitals, diagnostic centers, research laboratories, and veterinary clinics. Geographically, the CT scanner market is segmented into North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Russia, and the Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Type-Based InsightsThe CT scanner market is divided into stationary and portable CT scanners. The stationary CT scanners segment held a larger market share in 2022 and is expected to exhibit the highest CAGR from 2022 to 2030.
Architecture-Based Insights
The CT scanner market is categorized by architecture into C-arm CT Scanners and O-arm CT Scanners, with the C-arm CT Scanners segment leading the market in 2022.
Technology-Based Insights
The CT scanner market is segmented by technology into high slice CT, midsize CT, low slice CT, and cone beam CT, with the high slice CT segment holding the largest market share in 2022.
Application-Based Insights
The CT scanner market is segmented by application into oncology, neurology, orthopedics, and other applications, with the neurology applications segment holding the largest market share in 2022.
End User-Based Insights
The CT scanner market is categorized by end users into hospitals, diagnostic centers, research laboratories, and veterinary clinics. The hospital segment held the largest market share in 2022 and is projected to register the highest CAGR from 2022 to 2030.
CT Scanner Market Report Scope Regional Analysis
North America is anticipated to achieve the highest CAGR in the global CT scanner market from 2022 to 2030. North America held the largest market share in 2022 and is expected to maintain its leading position throughout the forecast period. The North American market is segmented into the US, Canada, and Mexico, with the US holding the largest share due to the rising prevalence of inflammatory diseases, the presence of major industry players, advancements in the healthcare sector, the introduction of innovative CT scan systems, and technological progress in CT scans in the region.
Key players in the global CT scanner market include GE Healthcare, Siemens Healthcare Private Limited, Koninklijke Philips N.V., TOSHIBA IT and CONTROL SYSTEMS CORPORATION, HTSI Healthcare Solutions, Shimadzu Corporation, SAMSUNGHEALTHCARE.COM, Neusoft Corporation, Medtronic, and Shenzhen Anke High-Tech Co., Ltd. These leading companies are focused on expanding and diversifying their market presence and clientele, which is expected to positively impact the CT scanner market.
Some notable developments by major market players include:
In November 2022, FUJIFILM launched the SCENARIA View Focus Edition, a premium CT scanner in the US, featuring Cardio StillShot, an advanced Cardiac Motion Correction technology that provides 6x higher temporal resolution than traditional image reconstruction methods. This device is suitable for both routine and advanced clinical applications and was introduced at RSNA 2022.
In April 2022, Wipro GE Healthcare launched its advanced Revolution Aspire CT scanner, designed and manufactured entirely in India at the Wipro GE Medical Devices Manufacturing plant, offering enhanced imaging intelligence for more accurate clinical diagnoses.In November 2021, Siemens Healthineers launched Naeotom Alpha, the first photon-counting CT scanner approved for clinical use in the USA and Europe, which offers significant improvements, including enhanced resolution and a reduction in radiation dose by up to 45% for ultra-high-resolution scans compared to conventional CT detectors.